#cstblog wyniki wyszukiwania

🗣 Give me ANYTHING but rabbit! You asked, we listened. Our new recombinant monoclonal portfolio has the neuronal and glial cell antibodies you trust, now in mouse, horse, and feline hosts. Learn how to plex with confidence on the #CSTblog 👇 hubs.ly/Q03LKYlM0


🔬📚 The proof is in the publishing: For nine consecutive years, CST antibodies have led @CiteAb's Top 100. Our rigorous validation means better antibodies, and better antibodies mean better science. Read the full story on the #CSTblog. hubs.ly/Q03R5Vsf0

CellSignal's tweet image. 🔬📚 The proof is in the publishing: For nine consecutive years, CST antibodies have led @CiteAb's Top 100.

Our rigorous validation means better antibodies, and better antibodies mean better science. Read the full story on the #CSTblog. 
hubs.ly/Q03R5Vsf0

Put the brakes on variability—standardize CAR expression in your flow cytometry experiments using Posibeads™ positive control beads from CST. Learn how Posibeads control beads enable accurate data comparison across multiple experiments on the #CSTblog. hubs.ly/Q03zkYFj0

blog.cellsignal.com

Confident CAR T Cell Detection: Positive Controls for Flow Cytometry

Use Posibeads positive controls in your flow cytometry panel to standardize engineered CAR T and CAR NK cell detection for confident data interpretation.


~60% of our antibodies are shipped at room temperature, eliminating the need for cold chain shipping and significantly reducing greenhouse gas emissions Learn more about our ambient shipping practices and how we guarantee product stability on the #CSTBlog hubs.ly/Q03Ck1y-0


When >50% of research reagents reportedly don’t perform as promised by manufacturers, how can you be sure your antibody will work? Explore tips for selecting the right reagent on the #CSTblog: hubs.ly/Q038pNcf0


🔬🧐 Are you using a flawed Bax antibody? A widely used reagent may be binding to the wrong protein—costing millions in wasted research & calling into question the validity of over 1,500 peer-reviewed studies. Read the #CSTBlog: hubs.ly/Q03gBC6f0


Parkinson’s research is evolving—fast. CST Associate Director of Neuroscience Richard W. Cho explores 10 key biomarkers linked to PD diagnosis, disease progression, and mitochondrial dysfunction on the #CSTBlog. Read it now 👇 hubs.ly/Q03tNPl30

blog.cellsignal.com

Top 10 Biomarkers Powering Parkinson’s Research | CST Blog

From α-synuclein to LRRK2, explore the top 10 Parkinson’s biomarkers researchers are studying to uncover disease mechanisms and enable early diagnosis.


🧠🔬 Explore key biofluid targets for AD, PD, ALS, and more—plus the antibodies and ELISA kits to detect them on the #CSTblog: hubs.ly/Q03mvYBZ0


🔬💡Epithelial-mesenchymal transition (EMT) is key to tackling cancer metastasis & treatment resistance. Our latest #CSTblog explores the most important EMT markers, including E-cadherin, N-cadherin, vimentin, and more, and how they’re shaping the... hubs.ly/Q03qHTDy0


🔬How does the extracellular matrix (ECM) influence cancer progression in the tumor microenvironment (TME)? Explore key markers and the antibody tools researchers are using to study tumor growth, immune evasion, and drug resistance on the #CSTBlog: hubs.ly/Q03pw4PS0


✅ 🧬 Cross-validation using orthogonal data sources adds rigor and reproducibility to your antibody validation workflows. Learn how CST scientists use orthogonal data sources like RNA-seq and mass spec to confirm antibody specificity on the #CSTblog hubs.ly/Q03fBFjg0


🔬💡mRNA ≠ protein. Learn why transcript levels don’t tell the whole story—and what measuring intracellular PTMs along with mRNA can reveal about single cell signaling on the #CSTBlog: hubs.ly/Q03jxtMn0


🧪 What makes a research antibody reliable? Orthogonal data helps. 👩‍🔬🔬 Learn how CST scientists use orthogonal data sources like RNA-seq and mass spec to confirm antibody specificity on the #CSTblog: hubs.ly/Q03vBK-l0


🔬 🧬 What if you could measure RNA, cell type & intracellular signaling at the single cell level? Researchers have long attempted such a scRNA-seq assay, but methodologies often lack reproducibility. Learn more about the InTraSeq assay on the #CSTBlog: hubs.ly/Q037mQ5q0


🗣 Give me ANYTHING but rabbit! You asked, we listened. Our new recombinant monoclonal portfolio has the neuronal and glial cell antibodies you trust, now in mouse, horse, and feline hosts. Learn how to plex with confidence on the #CSTblog 👇 hubs.ly/Q03LKYlM0


~60% of our antibodies are shipped at room temperature, eliminating the need for cold chain shipping and significantly reducing greenhouse gas emissions Learn more about our ambient shipping practices and how we guarantee product stability on the #CSTBlog hubs.ly/Q03Ck1y-0


🔬📚 The proof is in the publishing: For nine consecutive years, CST antibodies have led @CiteAb's Top 100. Our rigorous validation means better antibodies, and better antibodies mean better science. Read the full story on the #CSTblog. hubs.ly/Q03R5Vsf0

CellSignal's tweet image. 🔬📚 The proof is in the publishing: For nine consecutive years, CST antibodies have led @CiteAb's Top 100.

Our rigorous validation means better antibodies, and better antibodies mean better science. Read the full story on the #CSTblog. 
hubs.ly/Q03R5Vsf0

Put the brakes on variability—standardize CAR expression in your flow cytometry experiments using Posibeads™ positive control beads from CST. Learn how Posibeads control beads enable accurate data comparison across multiple experiments on the #CSTblog. hubs.ly/Q03zkYFj0

blog.cellsignal.com

Confident CAR T Cell Detection: Positive Controls for Flow Cytometry

Use Posibeads positive controls in your flow cytometry panel to standardize engineered CAR T and CAR NK cell detection for confident data interpretation.


Parkinson’s research is evolving—fast. CST Associate Director of Neuroscience Richard W. Cho explores 10 key biomarkers linked to PD diagnosis, disease progression, and mitochondrial dysfunction on the #CSTBlog. Read it now 👇 hubs.ly/Q03tNPl30

blog.cellsignal.com

Top 10 Biomarkers Powering Parkinson’s Research | CST Blog

From α-synuclein to LRRK2, explore the top 10 Parkinson’s biomarkers researchers are studying to uncover disease mechanisms and enable early diagnosis.


🧪 What makes a research antibody reliable? Orthogonal data helps. 👩‍🔬🔬 Learn how CST scientists use orthogonal data sources like RNA-seq and mass spec to confirm antibody specificity on the #CSTblog: hubs.ly/Q03vBK-l0


🔬💡Epithelial-mesenchymal transition (EMT) is key to tackling cancer metastasis & treatment resistance. Our latest #CSTblog explores the most important EMT markers, including E-cadherin, N-cadherin, vimentin, and more, and how they’re shaping the... hubs.ly/Q03qHTDy0


🔬How does the extracellular matrix (ECM) influence cancer progression in the tumor microenvironment (TME)? Explore key markers and the antibody tools researchers are using to study tumor growth, immune evasion, and drug resistance on the #CSTBlog: hubs.ly/Q03pw4PS0


✅ 🧬 Cross-validation using orthogonal data sources adds rigor and reproducibility to your antibody validation workflows. Learn how CST scientists use orthogonal data sources like RNA-seq and mass spec to confirm antibody specificity on the #CSTblog hubs.ly/Q03fBFjg0


🧠🔬 Explore key biofluid targets for AD, PD, ALS, and more—plus the antibodies and ELISA kits to detect them on the #CSTblog: hubs.ly/Q03mvYBZ0


Is your research antibody reliable? CST Principal Scientist Srikanth Subramanian explains how we collaborate with @YCharOS1 for independant antibody validation on the #CSTBlog. hubs.ly/Q03lrM_p0


🔬💡mRNA ≠ protein. Learn why transcript levels don’t tell the whole story—and what measuring intracellular PTMs along with mRNA can reveal about single cell signaling on the #CSTBlog: hubs.ly/Q03jxtMn0


🔬🧐 Are you using a flawed Bax antibody? A widely used reagent may be binding to the wrong protein—costing millions in wasted research & calling into question the validity of over 1,500 peer-reviewed studies. Read the #CSTBlog: hubs.ly/Q03gBC6f0


🌿🗣️ This #EarthMonth, learn why tropical forests are one of our best defenses against climate change from guest blogger Greg Powell of @ReforestTropics & why CST is a proud sponsor of a 25-year reforestation project in Costa Rica on the #CSTBlog: hubs.ly/Q03fzSpt0


When >50% of research reagents reportedly don’t perform as promised by manufacturers, how can you be sure your antibody will work? Explore tips for selecting the right reagent on the #CSTblog: hubs.ly/Q038pNcf0


🔬📚 The proof is in the publishing: For nine consecutive years, CST antibodies have led @CiteAb's Top 100. Our rigorous validation means better antibodies, and better antibodies mean better science. Read the full story on the #CSTblog. hubs.ly/Q03R5Vsf0

CellSignal's tweet image. 🔬📚 The proof is in the publishing: For nine consecutive years, CST antibodies have led @CiteAb's Top 100.

Our rigorous validation means better antibodies, and better antibodies mean better science. Read the full story on the #CSTblog. 
hubs.ly/Q03R5Vsf0

🙋Want to get our newest blog posts right in the palm of your gloved hand? Subscribe to our Lab Expectations Blog and other CST newsletters here: hubs.ly/H0bgTgS0 #CSTblog #science

CellSignal's tweet image. 🙋Want to get our newest blog posts right in the palm of your gloved hand? Subscribe to our Lab Expectations Blog and other CST newsletters here: hubs.ly/H0bgTgS0 #CSTblog #science

Hot off the (Cell) press! Meet the winners of the 3rd annual Rising Black Scientists Awards, an essay competition created by CST, @CellPressNews, & @ElsFoundation to support talented scientists on their journeys. #BlackinSTEM #CSTBlog hubs.ly/Q01CCH5x0

CellSignal's tweet image. Hot off the (Cell) press! Meet the winners of the 3rd annual Rising Black Scientists Awards, an essay competition created by CST, @CellPressNews, & @ElsFoundation to support talented scientists on their journeys. #BlackinSTEM #CSTBlog
hubs.ly/Q01CCH5x0

Speed CAR-T research w/ anti-CAR linker mAbs, winner of the 2023 @CiteAb Innovation Award. Learn more on the #CSTBlog: hubs.ly/Q01MKLX-0 #ImmunoOncology #CARTtherapy #CancerResearch

CellSignal's tweet image. Speed CAR-T research w/ anti-CAR linker mAbs, winner of the 2023 @CiteAb Innovation Award. Learn more on the #CSTBlog:  hubs.ly/Q01MKLX-0  #ImmunoOncology #CARTtherapy #CancerResearch

This #CancerImmunotherapyAwarenessMonth, learn about the promising immunotherapies with recent therapeutic developments, including checkpoint inhibitors, targeted antibodies, adoptive cell therapy, and cancer vaccines. Read the round-up on the #CSTBlog: hubs.ly/Q01VjM740

CellSignal's tweet image. This #CancerImmunotherapyAwarenessMonth, learn about the promising immunotherapies with recent therapeutic developments, including checkpoint inhibitors, targeted antibodies, adoptive cell therapy, and cancer vaccines. Read the round-up on the #CSTBlog:
hubs.ly/Q01VjM740

Networking and self-promotion are essential parts of any scientist's career and you want to be prepared. This #CSTblog post will share tips on how to craft an effective elevator pitch and adapt it for networking in an increasingly online world. hubs.ly/Q02dvR1d0

CellSignal's tweet image. Networking and self-promotion are essential parts of any scientist's career and you want to be prepared. This #CSTblog post will share tips on how to craft an effective elevator pitch and adapt it for networking in an increasingly online world.
hubs.ly/Q02dvR1d0

🎉 Through the comprehensive validation testing process we developed with @ProteinSimple, a @BioTechne brand, we've validated +500 antibodies for Simple Western workflows! Learn more in the latest #CSTBlog. hubs.ly/Q02VwnRT0

CellSignal's tweet image. 🎉 Through the comprehensive validation testing process we developed with @ProteinSimple, a @BioTechne brand, we've validated +500 antibodies for Simple Western workflows! Learn more in the latest #CSTBlog.
hubs.ly/Q02VwnRT0

Still designing a new reagent to detect every CAR-T cell iteration? There’s a faster way! Speed your research with anti-CAR linker antibodies: hubs.ly/Q01N48PL0 #CSTBlog #Immunotherapy #CancerResearch #CARTtherapy

CellSignal's tweet image. Still designing a new reagent to detect every CAR-T cell iteration? There’s a faster  way! Speed your research with anti-CAR linker antibodies:  hubs.ly/Q01N48PL0  #CSTBlog #Immunotherapy #CancerResearch #CARTtherapy

Meet Admirabilis (Bilis) Kalolella, 1 of the 4 winners of the 3rd annual Rising Black Scientists Awards. The essay competition was created by CST, @CellPressNews, & @ElsFoundation to support talented young scientists on their journeys. Read the #CSTBlog: hubs.ly/Q01D1r3n0

CellSignal's tweet image. Meet Admirabilis (Bilis) Kalolella, 1 of the 4 winners of the 3rd annual Rising Black Scientists Awards. The essay competition was created by CST, @CellPressNews, & @ElsFoundation to support talented young scientists on their journeys. Read the #CSTBlog: hubs.ly/Q01D1r3n0

Meet Elijah Persad-Paisley, 1 of the 4 winners of the 3rd annual Rising Black Scientists Awards. The essay competition was created by CST, @CellPressNews, & @ElsFoundation to support talented scientists on their journeys. Read the #CSTBlog: hubs.ly/Q01D1lnh0 #BlackinSTEM

CellSignal's tweet image. Meet Elijah Persad-Paisley, 1 of the 4 winners of the 3rd annual Rising Black Scientists Awards. The essay competition was created by CST, @CellPressNews, & @ElsFoundation to support talented scientists on their journeys. Read the #CSTBlog: hubs.ly/Q01D1lnh0 #BlackinSTEM

As technology makes leaps and bounds, the good news is that solutions are here for the taking. Click the link to read the full article on “Technology: Supporting industry Challenges.” - bit.ly/36gd4d3 #CSTblog #technology #solutions

callsystemstech's tweet image. As technology makes leaps and bounds, the good news is that solutions are here for the taking. Click the link to read the full article on “Technology: Supporting industry Challenges.” - bit.ly/36gd4d3 #CSTblog #technology #solutions

Now that we’re in full swing of summer, restaurants, pubs, and bars fill up quickly both inside and out. Click the link to read the full blog post on Restaurant Solutions That’ll See You Through the Summer! bit.ly/3wZbOqq #cstblog #hospitality #summer

callsystemstech's tweet image. Now that we’re in full swing of summer, restaurants, pubs, and bars fill up quickly both inside and out. Click the link to read the full blog post on Restaurant Solutions That’ll See You Through the Summer! bit.ly/3wZbOqq
#cstblog  #hospitality #summer

Are you ready for the #SummerRush? In the #hospitality world connectivity equals productivity. And what does productivity equal? You guessed it: profit. Read our latest #CSTblog on solutions to manage the #summer rush bit.ly/3rJ5PFU #CST #Technology #Productivity

callsystemstech's tweet image. Are you ready for the #SummerRush? In the #hospitality world connectivity equals productivity. And what does productivity equal? You guessed it: profit. Read our latest #CSTblog on solutions to manage the #summer rush bit.ly/3rJ5PFU

#CST #Technology #Productivity

Two-way radios increase the output of a manufacturing plant while also ensuring a consistent workflow. Click the link to read the full article on "How to Increase Productivity: Two-Way Radios" - bit.ly/3ws7Ntx #cstblog #twowayradio #communication

callsystemstech's tweet image. Two-way radios increase the output of a manufacturing plant while also ensuring a consistent workflow.  Click the link to read the full article on "How to Increase Productivity: Two-Way Radios" - bit.ly/3ws7Ntx #cstblog #twowayradio #communication

Loading...

Something went wrong.


Something went wrong.


United States Trends